Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
C
C
Koenecke
Department of Medicine and Hematology, University Hospital, Basel, Switzerland.
D
D
Heim
Department of Medical Statistics & BioInformatics, LUMC, Leiden, The Netherlands.
A
A
van Biezen
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
M
M
Heuser
Department of Hematology, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
M
M
Aljurf
Department of Hematology, Silesian Medical Academy University, Katowice, Poland.
S
S
Kyrcz-Krzemien
Stem Cell Transplantation Unit, Helsinki University Central Hospital, Helsinki, Finland.
L
L
Volin
Cidade Universitaria 'Zeferino Vaz', Campinas SP, Brazil.
C A
CA
de Souza
Department of Medicine, Rikshospitalet, The National Hospital, Oslo, Norway.
T
T
Gedde-Dahl
BMT Unit, Rigshospitalet, Copenhagen, Denmark.
H
H
Sengeloev
Division of Medicine, University Hospital, Zürich, Switzerland.
U
U
Schanz
Department of Hematology, K Marcinkowski University of Medical Science, Poznań, Poland.
M
M
Komarnicki
Department of Hematology, Hospital Reina Sofia Córdoba, Córdoba, Spain.
C H
CH
Arroyo
Department of Hematology, Manchester Royal Infirmary, Manchester, UK.
E
E
Tholouli
Department of Hematology, Hopital St Louis, Paris, France.
E
E
Gluckman
Hospital Santa Creu I Sant Pau, Barcelona, Spain.
A
A
Esquirol
LIRIC INSERM U995, Université Lille 2, CHRU de Lille, Lille, France.
I
I
Yakoub-Agha
Department of Hematology, Ankara University School of Medicine, Ankara, Turkey.
G
G
Gürman
Department of Haematology, Imperial College, Hammersmith Hospital, London, UK.
E
E
Olavarria
Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany.
N
N
Kröger
D000293:Adolescent; D000328:Adult; D000465:Algorithms; D002648:Child; D003657:Decision Making; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000639:trends*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy / Q000379:methods*; D018570:Risk Assessment; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D055815:Young Adult